NDC 52389-172

Nauzene

Sodium Citrate

Nauzene is a Oral Syrup in the Human Otc Drug category. It is labeled and distributed by Alva-amco Pharmacal Companies, Inc.. The primary component is Trisodium Citrate Dihydrate; Dextrose; Fructose.

Product ID52389-172_b35b5e0f-9b2e-40ae-9db7-65f245e40844
NDC52389-172
Product TypeHuman Otc Drug
Proprietary NameNauzene
Generic NameSodium Citrate
Dosage FormSyrup
Route of AdministrationORAL
Marketing Start Date2000-02-15
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart357
Labeler NameAlva-Amco Pharmacal Companies, Inc.
Substance NameTRISODIUM CITRATE DIHYDRATE; DEXTROSE; FRUCTOSE
Active Ingredient Strength1 g/15mL; g/15mL; g/15mL
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 52389-172-04

118 mL in 1 BOTTLE, PLASTIC (52389-172-04)
Marketing Start Date2000-02-15
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 52389-172-04 [52389017204]

Nauzene SYRUP
Marketing CategoryOTC monograph not final
Application Numberpart357
Product TypeHUMAN OTC DRUG
Marketing Start Date2000-02-15
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
TRISODIUM CITRATE DIHYDRATE.921 g/15mL

OpenFDA Data

SPL SET ID:728376f5-6cab-404e-b519-f6c595291d6f
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 895045
  • UPC Code
  • 0072959720049
  • NDC Crossover Matching brand name "Nauzene" or generic name "Sodium Citrate"

    NDCBrand NameGeneric Name
    52389-172NauzeneSodium Citrate
    52389-242NauzeneSodium Citrate
    62646-798Anticoagulant Sodium CitrateSodium Citrate

    Trademark Results [Nauzene]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    NAUZENE
    NAUZENE
    74469794 1909137 Live/Registered
    ALVA-AMCO PHARMACAL COS., INC.
    1993-12-16

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.